| NCT05564169 | Masitinib in Patients With Mild Alzheimer's Disease | NOT_YET_RECRUITING | PHASE3 | 2026-06 | 2029-12 | 2028-12 |
| NCT07174492 | Efficacy and Safety of Masitinib in Combination With SoC Versus Placebo in the Treatment of ALS Patients | NOT_YET_RECRUITING | PHASE3 | 2026-01-01 | 2029-12-31 | 2028-12-31 |
| NCT06974084 | Investigating Measurable PRO Acuity Trial (IMPACT) is a Multi-Center Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Maraviroc and Atorvastatin to Improve Neurocognitive and Physical Function of Subjects With Long COVID-19/Post-Acute Sequelae of COVID-19 (PASC). | NOT_YET_RECRUITING | PHASE2, PHASE3 | 2025-09-01 | 2026-04 | 2026-02-01 |
| NCT07016438 | Clinical Study of PAL-222 Targeting Patients With Refractory Skin Ulcer | RECRUITING | NA | 2025-04-15 | 2025-12-31 | 2025-12-01 |
| NCT06759389 | The VENTOR Clinical Study | RECRUITING | NA | 2025-04-04 | 2026-06 | 2026-06 |
| NCT06839209 | Advantages and Disadvantages of TOXCLEAN As Add on Treatment to SOC in Patients with Clostridium Difficile-associated Diarrhea | RECRUITING | NA | 2025-01-27 | 2025-12-31 | 2025-12-31 |
| NCT06779071 | Pivotal Clinical Trial to Evaluate the Efficacy and Safety After NPNP-001 Application in Patients with Knee Osteoarthritis. | ENROLLING_BY_INVITATION | PHASE3 | 2025-01-08 | 2026-06 | 2025-05 |
| NCT07005323 | Progression Suppression and Retinal Regression in VEGF-resistant AMD | RECRUITING | NA | 2024-09-12 | 2027-03 | 2027-03 |
| NCT07162610 | Efficacy and Safety of Rejuviel V in the Correction of Midface Volume Deficit | ACTIVE_NOT_RECRUITING | NA | 2024-04-07 | 2026-03-30 | 2026-03-08 |
| NCT06367426 | A Phase I Study of DDN-A-0101 in Healthy Volunteers and Elder People | RECRUITING | PHASE1 | 2024-04 | 2025-05 | 2025-05 |
| NCT05658237 | Clinical Study of PAL-222 Targeting Patients With Myopic Chorioretinal Atrophy (PAMyCA) | ACTIVE_NOT_RECRUITING | NA | 2023-02-17 | 2026-03-31 | 2026-01-31 |
| NCT05732610 | MGC Health COVID-19 & Flu A+B Home Multi Test Usability Study | COMPLETED | NA | 2023-02-14 | 2023-03-02 | 2023-02-28 |
| NCT05449444 | Masitinib for the Treatment of Severe Mast Cell Activation Syndrome | UNKNOWN | PHASE2 | 2022-07-01 | 2024-12-31 | 2024-12-31 |
| NCT05441488 | Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis | ACTIVE_NOT_RECRUITING | PHASE3 | 2022-06-28 | 2028-12 | 2028-12 |
| NCT05211570 | AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia | RECRUITING | PHASE1, PHASE2 | 2022-06-01 | 2026-12 | 2026-08 |
| NCT05342038 | Study on the Efficacy and Safety of T-02 for the Treatment for Acute Ischemic Stroke | WITHDRAWN | NA | 2022-04-22 | 2023-04-30 | 2023-01-31 |
| NCT05363449 | Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis | COMPLETED | PHASE1 | 2022-02-17 | 2023-11-14 | 2023-11-14 |
| NCT05047783 | Masitinib in Patients With Symptomatic Mild to Moderate COVID-19 | UNKNOWN | PHASE2 | 2021-11-23 | 2023-12 | 2023-12 |
| NCT03127267 | Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients | RECRUITING | PHASE3 | 2021-02-02 | 2027-12 | 2027-12 |
| NCT04676854 | Restoration of Central Vision With the PRIMA System in Patients With Atrophic AMD | ACTIVE_NOT_RECRUITING | NA | 2020-11-24 | 2028-02 | 2024-02-01 |
| NCT04333108 | Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment | UNKNOWN | PHASE3 | 2020-07-01 | 2025-06 | 2024-12 |
| NCT04622865 | Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19 | UNKNOWN | PHASE2 | 2020-06-01 | 2023-12 | 2023-12 |
| NCT04080206 | A Safety Study of 188-0551 Spray Versus Reference Listed Drug (RLD) in Adult Subjects With Plaque Psoriasis | COMPLETED | PHASE2 | 2020-04-07 | 2021-01-20 | 2021-01-20 |
| NCT04272008 | The Effects of Annoveraā¢ and Tampon Co-Usage on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol | COMPLETED | PHASE1 | 2020-03-06 | 2021-06-08 | 2021-06-08 |
| NCT04290390 | Annoveraā¢ Drug-Drug Interaction Study | COMPLETED | PHASE1 | 2020-02-12 | 2021-01-06 | 2021-01-06 |
| NCT04243486 | A Study of the Safety and Efficacy of UHE-105 Shampoo in Subjects With Scalp Psoriasis | COMPLETED | PHASE2 | 2020-01-02 | 2020-06-15 | 2020-06-15 |
| NCT04046328 | Efficacy, Safety and Tolerability of Enteric-Coated Cholestyramine Capsules for Adult Short Bowel Syndrome | TERMINATED | PHASE2 | 2019-10-15 | 2021-12-22 | 2021-12-22 |
| NCT03897257 | A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis | COMPLETED | PHASE2 | 2019-03-15 | 2020-05-05 | 2019-10-21 |
| NCT03759197 | A Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis | COMPLETED | PHASE3 | 2018-11-26 | 2019-08-27 | 2019-08-27 |
| NCT03731052 | Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis (307) | COMPLETED | PHASE3 | 2018-10-16 | 2019-12-20 | 2019-12-20 |
| NCT03392324 | PRIMA US-Feasibility Study in Atrophic Dry AMD | ACTIVE_NOT_RECRUITING | NA | 2018-04-26 | 2025-12 | 2025-12 |
| NCT03333954 | Feasibility Study of Compensation for Blindness With the PRIMA System in Patients With Dry Age Related Macular Degeneration | COMPLETED | NA | 2017-11-06 | 2024-12-12 | 2024-12-12 |
| NCT03317028 | CS02 vs Placebo With Metformin in Type 2 Diabetes Mellitus (T2DM) | COMPLETED | PHASE2 | 2017-10-10 | 2020-04-21 | 2020-04-21 |
| NCT03307577 | A Phase 2 Safety and Efficacy Study of UHE-101 Cream in Subjects With Acne Vulgaris | COMPLETED | PHASE2 | 2017-10-05 | 2018-05-31 | 2018-05-31 |
| NCT05200169 | Mass Balance Recovery, Metabolite Profile and Metabolite Identification of 14C-AB1010 in Healthy Male Subjects | COMPLETED | EARLY_PHASE1 | 2017-07-31 | 2017-09-01 | 2017-09-01 |
| NCT03062787 | Early Effect of CingalĀ® Compared to MonoviscĀ® in Patients With Osteoarthritis of the Knee | COMPLETED | NA | 2017-04-05 | 2017-10-25 | 2017-10-25 |
| NCT03039504 | Clinical Evaluation of Effectiveness and Safety of Dietary Supplement Potensa in Men With Erectile Dysfunction | COMPLETED | NA | 2017-01-31 | 2017-06-28 | 2017-06-28 |
| NCT03065556 | A Comparison of 188-0551 Solution Versus Vehicle Solution in Subjects With Plaque Psoriasis (Study 203) | COMPLETED | PHASE2 | 2017-01-26 | 2017-12-06 | 2017-07-06 |
| NCT03771040 | Masitinib in the Treatment of Patients With Severe Uncontrolled Asthma and Elevated Eosinophil Levels | COMPLETED | PHASE3 | 2016-12 | 2020-09 | 2020-09 |
| NCT02742441 | A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 310) | COMPLETED | PHASE3 | 2016-06 | 2017-06-16 | 2017-02-27 |
| NCT02670980 | Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy | COMPLETED | NA | 2016-01 | 2019-05 | 2019-05 |
| NCT03556956 | Masitinib in Combination With FOLFIRI in Third or Fourth Line of Treatment of Patients With Metastatic Colorectal Cancer | COMPLETED | PHASE2, PHASE3 | 2015-07 | 2020-12 | 2020-12 |
| NCT02009423 | Masitinib in Patients With Localized, Primary GIST After Complete Surgery and With High Risk of Recurrence | TERMINATED | PHASE3 | 2015-07 | 2015-11 | 2015-11 |
| NCT02368210 | A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 306) | COMPLETED | PHASE3 | 2015-01 | 2017-02 | 2015-06 |
| NCT02367911 | A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis | COMPLETED | PHASE3 | 2015-01 | 2017-02 | 2015-08 |
| NCT03761225 | Masitinib Plus Docetaxel in Metastatic Castration-resistant Prostate Cancer | COMPLETED | PHASE3 | 2014-09 | 2020-12-15 | 2020-12-15 |
| NCT02253173 | Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women | COMPLETED | PHASE3 | 2014-09 | 2015-10 | 2015-10 |
| NCT03766295 | Masitinib Plus Gemcitabine in Pancreatic Cancer | COMPLETED | PHASE3 | 2014-07 | 2020-12 | 2020-12 |
| NCT02490488 | Masitinib in Combination With Gemcitabine in Advanced/Metastatic Epithelial Ovarian Cancer Patients | COMPLETED | PHASE2, PHASE3 | 2014-04 | 2020-12 | 2020-12 |
| NCT02019589 | A Phase 3, Randomized, Three-Cycle, Double-Blind, Placebo-Controlled Study to Evaluate Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding for Secondary Amenorrhea | TERMINATED | PHASE3 | 2014-01-20 | 2014-10-31 | 2014-10-31 |
| NCT02605044 | Masitinib in Combination With FOLFIRI for Second-line Treatment of Patients With Metastatic Colorectal Cancer | TERMINATED | PHASE3 | 2014-01 | 2017-12 | 2017-12 |
| NCT02209155 | R-Verapamil for the Prophylaxis of Episodic Cluster Headache | TERMINATED | PHASE2 | 2013-11 | 2018-03 | 2018-03 |
| NCT01942668 | A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor Symptoms | COMPLETED | PHASE3 | 2013-08-05 | 2016-10-28 | 2016-10-28 |
| NCT02449902 | TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy | COMPLETED | PHASE2 | 2013-07 | 2013-09 | 2013-09 |
| NCT01882647 | A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305) | COMPLETED | PHASE3 | 2013-06 | 2014-03 | 2014-03 |
| NCT01871402 | A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304) | COMPLETED | PHASE3 | 2013-05 | 2013-12 | 2013-12 |
| NCT02588677 | Masitinib in Combination With Riluzole for the Treatment of Patients Suffering From Amyotrophic Lateral Sclerosis (ALS) | COMPLETED | PHASE2, PHASE3 | 2013-04 | 2018-03 | 2016-12-05 |
| NCT01864486 | Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal Dystrophy | COMPLETED | NA | 2013-04 | 2017-10-13 | 2017-10-13 |
| NCT01700985 | A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis | COMPLETED | PHASE2 | 2012-05 | 2013-03 | 2012-09 |
| NCT01694277 | Masitinib in Patients With Gastrointestinal Stromal Tumour After Progression With Imatinib | COMPLETED | PHASE3 | 2012-04 | 2020-12 | 2020-12 |
| NCT01698333 | Pharmacokinetics of 122-0551 and Its Effects on Adrenal Suppression | COMPLETED | PHASE2 | 2012-04 | 2013-07 | 2013-03 |
| NCT01872598 | Masitinib in Patients With Mild to Moderate Alzheimer's Disease | COMPLETED | PHASE3 | 2012-01 | 2020-12 | 2020-12 |
| NCT01610596 | A Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis | COMPLETED | PHASE2 | 2011-11 | 2012-02 | 2012-02 |
| NCT01433497 | Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis | COMPLETED | PHASE3 | 2011-08 | 2020-02 | 2019-09 |
| NCT01410695 | Masitinib in Refractory Active Rheumatoid Arthritis | TERMINATED | PHASE2, PHASE3 | 2011-07 | 2015-10 | 2015-10 |
| NCT01470131 | A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Patients With Relapse or Refractory Multiple Myeloma | TERMINATED | PHASE3 | 2011-05 | 2017-02-01 | 2017-01-04 |
| NCT01449162 | Masitinib in Treatment of Patients With Severe Persistent Asthma Treated With Oral Corticosteroids | COMPLETED | PHASE3 | 2011-01 | 2019-11 | 2019-11 |
| NCT01280565 | Masitinib in Non-Resectable or Metastatic Stage 3/4 Melanoma Carrying a Mutation in the Juxta Membrane Domain of c-Kit | TERMINATED | PHASE3 | 2011-01 | 2019-08 | 2019-08 |
| NCT01166646 | Blinded Study of Topical Investigational Lotion Vs. Approved Cream in Treatment of Plaque Psoriasis | COMPLETED | PHASE2 | 2010-07 | 2011-07 | 2011-07 |
| NCT00812240 | Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST) | TERMINATED | PHASE3 | 2009-01 | 2018-07 | 2018-07 |
| NCT00814073 | Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis | COMPLETED | PHASE3 | 2008-12 | 2015-11 | 2015-11 |
| NCT00789633 | Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer | COMPLETED | PHASE3 | 2008-11-25 | 2012-08-31 | 2011-12-23 |
| NCT01506336 | Masitinib in Patients With Gastro-Intestinal Stromal Tumour Resistant to Imatinib | COMPLETED | PHASE2 | 2008-10 | 2012-04 | 2011-09 |
| NCT00774917 | Numen Stent Assessment Using OCT Technique in a Single Center Study | UNKNOWN | PHASE2, PHASE3 | 2008-10 | 2010-03 | 2009-09 |
| NCT00790283 | Assessment of the Numen Stent With Evaluation in a Randomized Study | UNKNOWN | PHASE2, PHASE3 | 2008-09 | 2009-09 | 2009-09 |
| NCT00637104 | European Multicenter, Randomized, Comparative Efficacy/Safety Study of the Mar-Tyn TiN-Coated Stent | UNKNOWN | PHASE2, PHASE3 | 2008-07 | 2011-06 | 2010-12 |
| NCT00633165 | Brostallicin Clinical Trial for Myxoid Liposarcoma | UNKNOWN | PHASE2 | 2007-08 | 2010-06 | 2008-10 |
| NCT00913432 | Masitinib in Combination With Methotrexate, in Treatment of Patients With Active Rheumatoid Arthritis | COMPLETED | PHASE2 | 2007-03 | 2010-09 | 2009-06 |
| NCT01266369 | Masitinib in Patients With Mastocytosis With Handicap and Bearing the D816V Mutation | COMPLETED | PHASE2 | 2007-02 | 2010-05 | 2007-11 |
| NCT00976118 | Activity of Masitinib (AB1010) in Mild to Moderate Alzheimer's Disease | COMPLETED | PHASE2 | 2006-02 | 2009-02 | 2008-07 |
| NCT00842270 | Efficacy of Oral AB1010 in Adult Patients With Severe Persistent Corticosteroid Dependent Asthma | COMPLETED | PHASE2 | 2006-01 | | 2007-07 |
| NCT01045577 | A Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Activity of Oral AB1010 in Adults Patients With Moderate to Severe Chronic Plaque Psoriasis | COMPLETED | PHASE2 | 2005-09 | 2008-02 | 2006-01 |
| NCT01450488 | Masitinib in Primary Progressive Multiple Sclerosis or Relapse-free Secondary Progressive Multiple Sclerosis | COMPLETED | PHASE2 | 2005-06 | 2010-01 | 2007-07 |
| NCT00998751 | Masitinib in Locally Advanced/Metastatic Gastro-intestinal Stromal Tumour (GIST) | COMPLETED | PHASE2 | 2005-06 | 2013-06 | 2013-06 |
| NCT00866138 | Masitinib in Relapse or Refractory Multiple Myeloma With t(4/14) Translocation Expressing or Not FGFR3 | COMPLETED | PHASE2 | 2005-02 | 2011-01 | 2011-01 |
| NCT02225912 | A Study to Evaluate the Efficacy of the Nasal Antiseptic, PrevinC, When Administered for the RiskReduction of Rhinitis in Subjects Who Work for Child Day Care Centers | COMPLETED | PHASE4 | 2005-02 | 2005-05 | 2005-05 |
| NCT00831974 | Efficacy of AB1010 in Patients With Systemic Indolent Mastocytosis | COMPLETED | PHASE2 | 2004-10 | | 2007-02 |
| NCT00080132 | Implitapide in Patients With Hypertriglyceridemia (HTG) on Maximal, Concurrent Triglyceride-Lowering Therapy | TERMINATED | PHASE2 | 2004-10 | 2005-04 | |
| NCT00831922 | Efficacy of Oral AB1010 in Adult Patients With Active Rheumatoid Arthritis | COMPLETED | PHASE2 | 2004-09 | | 2006-10 |
| NCT00079859 | Implitapide in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) on Maximal Concurrent Lipid-Lowering Therapy | TERMINATED | PHASE2 | 2003-10 | 2005-04 | |
| NCT00079846 | Implitapide in Patients With Homozygous Familial Hypercholesterolemia (HoFH) on Maximal Concurrent Lipid-Lowering Therapy | TERMINATED | PHASE2 | 2003-09 | 2005-04 | |
| NCT00008489 | Comparing Side Effects of Two Forms of Videx in HIV-Infected Adults | UNKNOWN | PHASE3 | | | |